However, GRAPPA asserts that there is grade A evidence for use of infliximab or etanercept in severe enthesitis ... the target of all treatment strategies in psoriatic arthritis.

Researchers identified 3 distinct PsA phenotype clusters, emphasizing the importance of PsO severity in treatment decision making.

A study found patients treated with interleukin inhibitors did not experience a difference in the rates of major adverse ...

Arthritis can affect your fingers causing reduced mobility pain and swelling Read on to check the types of arthritis ...

Topline data were announced from two phase 3 trials evaluating deucravacitinib, a tyrosine kinase 2 (TYK2) inhibitor, in adults with active psoriatic ... treatment of adults with moderate to ...

Impact of Disease questionnaire (PsAID-12) scores were associated with treatment escalation, physicians primarily relied on clinical assessments when making treatment decisions.

For patients with psoriatic arthritis, switching directly from adalimumab to tofacitinib with no washout period presents no ...

LAPIX plans to submit a third IND for LPX-TI641 in the first quarter of 2025 with the dermatology division at the US-FDA.

The Waterloo Road actor appeared on This Morning and revealed he is turning to lifestyle changes to help manage his condition ...

Topline data were announced from two phase 3 trials evaluating deucravacitinib in adults with active psoriatic arthritis.